HPLC separates peptide-related species and is often cited on Certificates of Analysis. This guide explains what chromatographic purity reports mean—and what they do not claim—for laboratory reference standards.
High-performance liquid chromatography separates components in a dissolved sample as they travel through a column under controlled mobile-phase conditions. A detector records peaks over time. For peptide research materials, the main peak is typically associated with the intended sequence under the method’s conditions, while smaller peaks may represent related substances, process impurities, or degradation products detectable by that method.
The area of the main peak relative to total detected peak area is often reported as a chromatographic purity percentage on a CoA. That figure is method-dependent: different columns, gradients, or detection wavelengths can change what is resolved and therefore what percentage is calculated.
Because HPLC reports what the chosen method can see, it is best understood as a separation-based profile for that lot under stated conditions—not as a universal purity grade that transfers unchanged to every laboratory method.
A purity number without method context is incomplete. Laboratories reviewing a certificate should note whether the CoA names HPLC (or a related liquid chromatography approach), and whether any method parameters or chromatogram references are provided. Comparing two lots using different HPLC methods as if they were identical can mislead receiving or method-transfer decisions.
Invus Labs does not invent HPLC percentages for unpublished lots. When a lot certificate is published, chromatographic results appear only as stated on that document.
If your laboratory re-runs HPLC on the same vial under a different gradient, expect possible differences in peak resolution. Document your method version alongside the supplier CoA rather than treating the two chromatograms as interchangeable screenshots.
HPLC primarily addresses separation and relative peak areas. It does not by itself prove molecular identity with the same specificity as mass spectrometry. Many peptide CoAs therefore pair HPLC with MS data: chromatography for related-substance profiling, mass analysis for supporting identity.
Treating an HPLC purity figure as a complete characterization of a reference standard overstates what the technique provides. Use HPLC results alongside identity methods and your own system suitability criteria.
When unexpected shoulders or new peaks appear in your chromatogram, first confirm lot identity, solvent quality, and column history before assuming the CoA was wrong. Many investigations end in handling or method differences rather than label mismatches.
When incorporating a lyophilized peptide reference standard into an HPLC method, dissolve according to your SOP, confirm instrument suitability, and retain chromatograms with lot identifiers. If unexpected peaks appear, compare against the published CoA for that batch and investigate solvent, handling, and method differences before drawing conclusions.
Research catalog examples such as Ipamorelin, Tesamorelin, or Retatrutide reference standards illustrate the same workflow: lot documentation first, then analytical use under research-use-only constraints.
Training new analysts on how to read a CoA HPLC line—method named, result as printed, lot matched—reduces the temptation to round or “improve” numbers when writing reports.
Do not equate chromatographic purity with “clinical grade,” “pharmaceutical grade,” or fitness for administration. Those labels are outside research-use-only positioning. Do not copy a purity percentage from a brochure onto a lab notebook unless it matches the published CoA for the exact lot in hand.
Also avoid ranking suppliers solely by the largest purity number printed online. Without method and lot linkage, large numbers are weak evidence. Prefer transparent certificates over marketing adjectives.
For related reading, see articles on Certificates of Analysis, mass spectrometry, and understanding peptide purity.
When a purchase justification or method SOP mentions “HPLC purity,” require the writer to cite the lot CoA and the method name as printed. That small rule stops purity numbers from floating free of their analytical origin. Inventory software can store the percentage and a link to the certificate PDF so auditors see both.
If your laboratory develops an in-house HPLC method for a peptide reference standard, keep supplier CoA chromatograms as context only. Your acceptance criteria belong to your validated method. Invus Labs research materials remain research-use-only inputs; chromatographic work does not change that scope.
Teams comparing Ipamorelin, Tesamorelin, and Retatrutide lots should compare certificates method-by-method rather than building league tables of purity percentages stripped of context.
Invus Labs is a European warehouse and logistics company based in Germany. We supply lyophilized laboratory reference standards for in-vitro research use only.
Contact: support@invuslabs.com
Research use only. Not for human or veterinary use. Not a drug, food, supplement, cosmetic, or medical device.